|
Real-time
Euronext Paris
11:54:01 01/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 35.40 EUR | -1.26% |
|
-2.34% | -17.77% |
| 09-21 | Neurones S.A.(ENXTPA:NRO) added to S&P Global BMI Index | CI |
| 09-09 | NEURONES Reaffirms Earnings Guidance for the Full Year of 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 45 | +25.52% | 1 | ||||
| 240.59 | +9.39% | 22 | ||||||
| 281.08 | +22.44% | 53 | ||||||
| 336.81 | -3.02% | 31 | ||||||
| 425.14 | +25.2% | 48 | ||||||
| 193.03 | +5.27% | 24 | ||||||
| 2,465.83 | +20.25% | 41 | ||||||
| 34.01 | +36.24% | 17 | ||||||
| 141.58 | +62.51% | 38 | ||||||
| 4,833.85 | +22.16% | 13 | ||||||
| 1,197.29 | +20.44% | 42 | ||||||
| 6,273.08 | +31.82% | 13 | ||||||
| 1,339.1 | +144.38% | 23 | ||||||
| 212.25 | +1.5% | 43 | ||||||
| 1,269.15 | +3.18% | 39 | ||||||
| 28.15 | +24.99% | 15 | ||||||
| 65.1 | +13.34% | 25 | ||||||
| 324.4 | +15.03% | 5 | ||||||
| 69.06 | +33.28% | 22 | ||||||
| Average | 1,040.76 | +27.05% | 27 | ||||||
| Weighted average by Cap. | 820.65 | +21.27% | 32 |
- Stock Market
- Stocks
- NRO Stock
- Sector NEURONES
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
